BADBIR is an observational, prospective study open to patients undergoing treatment for psoriasis with either a biologic drug or a standard anti-psoriatic therapy. Please speak to your dermatologist if you are interested in becoming involved as several eligibility criteria apply.

For patients already on the Register, please visit the FAQ section to learn more about your participation in BADBIR. Latest patient newsletters can be viewed here.

If you have any questions about BADBIR please get in touch via email: badbir@manchester.ac.uk